 NEW YORK, NY, Jan. 20, 2021 GLOBE NEWSWIRE -- Enzo Biochem, Inc. NYSE:ENZ Enzo or the Company, a leading biosciences and diagnostics company, today announced that the Enzo Board of Directors has formed two new committees to support strategy related to targeting and execution of new business opportunities and development and support for new members of the leadership team within the Company. The establishment of the new board committees follows Enzos recent announcement of quarterly organic growth of 47 on a year-over-year basis, EBITDA of approximately 1 million, and anticipation of setting the company on track to achieve full year profitability from operations. 